V. Krčméry

发表

M. Karvaj, V. Krčméry, P. Kisac, 2010, Scandinavian journal of infectious diseases.

Breakthrough Fungemia Due to Candida glabrata During Posaconazole Prophylaxis in Hematology Patients Treated with Anidulafungin - Report of 5 Cases

V. Krčméry, P. Kisac, A. Demitrovicova, 2011, Journal of chemotherapy.

Etiology and Risk Factors of 339 Cases of Infective Endocarditis: Report from a 10-year National Prospective Survey in the Slovak Republic

V. Krčméry, M. Gogova, A. Ondrusova, 2003, Journal of chemotherapy.

Endocarditis due to enterococcus faecalis: risk factors and outcome in twenty-one cases from a five year national survey.

P. Marx, V. Krčméry, V. Hricák, 1998, Scandinavian journal of infectious diseases.

Etiology and risk factors of 180 cases of native valve endocarditis. Report from a 5-year national prospective survey in Slovak Republic.

T. Sedlak, P. Marx, V. Krčméry, 1998, Diagnostic microbiology and infectious disease.

Psychosocial support needs of Slovak breast cancer survivors one and three years after breast conserving surgery.

V. Bencová, I. Krajčovičová, V. Krčméry, 2013, Bratislavske lekarske listy.

Low incidence of quinolone resistance in gram-negative bacteria after five-years use of ofloxacin in prophylaxis during afebrile neutropenia.

J. Trupl, V. Krčméry, A. Kunová, 1996, The Journal of hospital infection.

Evolving trends in infective endocarditis: comparison with 156 cases from the National Survey in Slovakia.

V. Krčméry, V. Fischer, R. Jurco, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Detection of protein homolougs with HIV-1 antigens in bacteria of positive patients - phase II.

S. Ciernikova, V. Stevurková, Z. Adamcikova, 2014, Neuro endocrinology letters.

Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case-controlled study.

S. Špánik, J. Trupl, V. Krčméry, 1998, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Legal framework of antimicrobial stewardship in hospitals (LEASH): a European Society of Clinical Microbiology and Infectious Diseases (ESCMID) cross-sectional international survey.

O. Dyar, G. Béraud, M. Popovici, 2018, International journal of antimicrobial agents.

Emerging fungal infections in cancer patients.

V. Krčméry, 1996, The Journal of hospital infection.

Fungal resistance in Cambodian children with acquired immunodeficiency syndrome.

V. Krčméry, A. Doczeova, A. Líšková, 2006, The Pediatric infectious disease journal.

Trends in Risk Factors and Etiology of 606 Cases of Infective Endocarditis Over 23 Years (1984-2006) in Slovakia

B. Líška, M. Karvaj, V. Krčméry, 2007, Journal of chemotherapy.

Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis.

V. Rusňáková, S. Špánik, J. Trupl, 1997, Scandinavian journal of infectious diseases.

Documented fungal infections after prophylaxis or therapy with wide spectrum antibiotics: relationship between certain fungal pathogens and particular antimicrobials?

V. Krčméry, A. Kunová, M. Sulcova, 1999, Journal of chemotherapy.

Infective endocarditis after dental surgery

M. Karvaj, V. Krčméry, P. Kisac, 2010 .

First report of vancomycin-resistant Streptococcus mitis bacteremia in a leukemic patient after prophylaxis with quinolones and during treatment with vancomycin.

S. Špánik, J. Trupl, V. Krčméry, 1996, Journal of chemotherapy.

Bacteremia and fungemia in pediatric versus adult cancer patients after chemotherapy: comparison of etiology, risk factors and outcome.

E. Kaiserova, J. Trupl, V. Krčméry, 1998, Journal of chemotherapy.

Fungaemia due to thermophilic cryptococci: 3 cases of Cryptococcus laurentii bloodstream infections in cancer patients receiving antifungals.

V. Krčméry, A. Kunová, 1999, Scandinavian journal of infectious diseases.

V. Bencová, I. Krajčovičová, J. Svec, 2013 .

Invasive yeast infections other than Candida spp. in acute leukaemia.

D. Denning, V. Krčméry, I. Krupova, 1999, The Journal of hospital infection.

NosocomialCryptococcus laurentii fungemia in a bone marrow transplant patient after prophylaxis with ketoconazole successfully treated with oral fluconazole

J. Mardiak, V. Krčméry, A. Kunová, 1997, Infection.

Etiology, Risk Factors and Outcome of 1003 Cases of Infective Endocarditis from a 33-year National Survey in the Slovak Republic: An increasing proportion of elderly patients.

S. Špánik, R. Babela, V. Hricák, 2019, Neuro endocrinology letters.

Fungemia in cancer patients undergoing chemotherapy versus surgery: risk factors, etiology and outcome.

S. Špánik, P. Pichna, J. Trupl, 1997, Scandinavian journal of infectious diseases.

Neuroinfections in developed versus developing countries.

P. Fedor-Freybergh, V. Krčméry, 2007, Neuro endocrinology letters.

Bacteraemia and Fungaemia During Ofloxacin Prophylaxis in Cancer Patients

J. Trupl, V. Krčméry, A. Demitrovicova, 1999, Drugs.

Breakthrough Candidaemias During Empirical Therapy with Fluconazole in Non-cancer and Non-HIV Adults Caused by In Vitro-susceptible Candida Spp.: Report of 33 Cases

V. Krčméry, M. Huttová, J. Hanzen, 2001, Scandinavian journal of infectious diseases.

Breakthrough Candida tropicalis fungemia during ketoconazole prophylaxis in cancer patients.

V. Krčméry, E. Pichnova, D. Sejnová, 1999, Acta oncologica.

Risk factors, aetiology, therapy and outcome in 123 episodes of breakthrough bacteraemia and fungaemia during antimicrobial prophylaxis and therapy in cancer patients.

J. Šufliarský, J. Mardiak, S. Špánik, 1997, Journal of medical microbiology.

Eight-year surveillance of non-albicans Candida spp. in an oncology department prior to and after fluconazole had been introduced into antifungal prophylaxis.

S. Špánik, P. Pichna, J. Trupl, 1997, Microbial drug resistance.

Arcanobacterium haemolyticum invasive infections, including meningitis in cancer patients.

J. Šufliarský, J. Trupl, V. Krčméry, 1997, The Journal of infection.

Situation analysis in 3,503 refugees from Mosul to Dohuk and Healthcare in an UNHCR refugee camp in Dohuk

V. Krčméry, Z. Dudová, J. Benca, 2016 .

Endocarditis due to Gram-negative bacteria.

V. Hricák, V. Krčméry, P. Kisac, 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Native valve staphylococcal endocarditis: etiology, risk factors and outcome in 53 cases.

T. Sedlak, V. Krčméry, V. Hricák, 1998, Journal of chemotherapy.

Polymicrobial bacteremia in cancer patients: analysis of risk factors, etiology and outcome in 214 episodes.

S. Špánik, P. Pichna, J. Trupl, 1996, International journal of antimicrobial agents.

Bacteremia and fungemia occurring during antimicrobial prophylaxis with ofloxacin in cancer patients: risk factors, etiology and outcome.

V. Rusňáková, S. Špánik, P. Pichna, 1996, Journal of chemotherapy.

Invasive mold infections in cancer patients: 5 years' experience withAspergillus, Mucor, Fusarium andAcremonium infections

J. Mardiak, S. Špánik, J. Trupl, 2005, Supportive Care in Cancer.

Fluconazol plus ofloxacin in prophylaxis of infections in patients with acute leukemia: a comparative study

J. Mardiak, V. Krčméry, E. Tomasik, 1993, Supportive Care in Cancer.

Fluconazole in children: first experience with prophylaxis in chemotherapy-induced neutropenia in pediatric patients with cancer.

J. Trupl, E. Bubanská, V. Krčméry, 1993, Chemotherapy.

The Role of Bacteria and Yeasts in AIDS

L. Wachsmannova, V. Stevurková, Z. Adamcikova, 2011 .

Organization and training at national level of antimicrobial stewardship and infection control activities in Europe: an ESCMID cross-sectional survey

A. Barać, W. Zingg, A. Holmes, 2019, European Journal of Clinical Microbiology & Infectious Diseases.

Vancomycin resistance in Gram-positive bacteria other than Enterococcus spp.

A. Sefton, V. Krčméry, 2000, International journal of antimicrobial agents.

Nosocomial bacteremia due to vancomycin-resistantStaphylococcus epidermidis in four patients with cancer, neutropenia, and previous treatment with vancomycin

Ľ. Drgoňa, J. Trupl, V. Krčméry, 1996, European Journal of Clinical Microbiology and Infectious Diseases.

Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.

A. Barnes, V. Krčméry, V. Krcmery, 2002, The Journal of hospital infection.

Funguria in cancer patients: Analysis of risk factors, clinical presentation and outcome in 50 patients

Ľ. Ševčíková, S. Špánik, J. Silva, 1996, Infection.

Aetiology, antifungal susceptibility, risk factors and outcome in 201 fungaemic children: data from a 12-year prospective national study from Slovakia.

V. Krčméry, M. Huttová, K. Kralinsky, 2002, Journal of medical microbiology.

Fungal pathogens in etiology of septic shock in neutropenic patients with cancer (short communication).

Ľ. Drgoňa, J. Trupl, V. Krčméry, 1993, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

Systemic chlorellosis, an emerging infection in humans caused by algae.

V. Krčméry, Vladimir Krcmery, 2000, International journal of antimicrobial agents.

Acremonium infection in two compromized patients.

J. Mardiak, J. Trupl, V. Krčméry, 1993, The Journal of hospital infection.

Liposomal nystatin (L-NYS) in therapy of pulmonary aspergillosis refractory to conventional amphotericin B in cancer patients

M. Mistrik, V. Krčméry, E. Bojtárová, 2001, Supportive Care in Cancer.

Prevalence of non-pathogenic types of gastrointestinal protozoa in population in Slovakia and their potential importance in the aspect of public health

V. Krčméry, P. Juriš, Z. Vasilková, 2018, Acta Parasitologica.

Catheter-associated septicaemia due to Trichosporon capitatum.

J. Šufliarský, Z. Sycova-Mila, J. Trupl, 1992, The Journal of hospital infection.

Prospective study on fungemia in children with cancer: analysis of 35 cases and comparison with 130 fungemias in adults

R. Babela, E. Kaiserova, V. Krčméry, 2000, Supportive Care in Cancer.

Three cases of fatal infection due to Fusarium solani in patients with cancer.

J. Mardiak, J. Trupl, V. Krčméry, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fungaemia due to Fusarium spp. in cancer patients.

J. Šufliarský, J. Mardiak, S. Špánik, 1997, The Journal of hospital infection.

FatalTrichosporon pullulans breakthrough fungemia in cancer patients: Report of three patients who failed on prophylaxis with itraconazole

J. Šufliarský, S. Špánik, J. Godal, 1996, Infection.

First report of catheter associated Trichosporon pullulans breakthrough fungaemia in a cancer patient.

J. Šufliarský, V. Krčméry, A. Kunová, 1996, The Journal of infection.

First report of Prototheca wickerhami algaemia in an adult leukemic patient.

S. Špánik, V. Krčméry, A. Kunová, 1996, Journal of chemotherapy.

Report of catheter-associatedTrichosporon pullulons break-through fungemia in a cancer patient

J. Šufliarský, V. Krčméry, A. Kunová, 1995, European Journal of Clinical Microbiology and Infectious Diseases.

Successful treatment of catheter-associated fungemia due toCandida krusei andTrichosporon beigelii in a leukemic patient receiving prophylactic itraconazole

S. Špánik, V. Krčméry, A. Kunová, 1995, European Journal of Clinical Microbiology and Infectious Diseases.

Nosocomial outbreak of meropenem resistant Pseudomonas aeruginosa infections in a cancer centre.

J. Trupl, V. Krčméry, 1994, The Journal of hospital infection.

Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?

J. Billé, J. Trupl, V. Krčméry, 2000, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Aureobasidium mansoni meningitis in a leukemia patient successfully treated with amphotericin B.

S. Špánik, V. Krčméry, Z. Jesenská, 1994, Chemotherapy.

Susceptibility of Fungal or Yeast Bloodstream Isolates to Antifungals: Results from a National Study

J. Billé, J. Trupl, V. Krčméry, 2001, Chemotherapy.

Candidosis, aspergillosis and zygomycosis in an oncology department

J. Šufliarský, J. Mardiak, S. Špánik, 1992, Mycoses.

Epidemiological risks of endoparasitoses spread by municipal waste water

I. Papajová, V. Krčméry, P. Juriš, 2015 .

Transferable fluoroquinolone resistance in Enterobacteriaceae and Pseudomonas aeruginosa isolated from hemocultures.

V. Krčméry, N. Kulková, M. Babálová, 2014, Central European journal of public health.

Breakthrough fungemia appearing during empiric therapy with amphotericin B.

S. Špánik, J. Trupl, V. Krčméry, 1997, Chemotherapy.

Prospective national survey of viridans streptococcal bacteraemia risk factors, antibacterial susceptibility and outcome of 120 episodes

M. Karvaj, V. Krčméry, M. Kačmariková, 2005, Scandinavian journal of infectious diseases.

Resistance to Penicillin and Erythromycin in Viridans Streptococcal Bloodstream Isolates From Cancer and Non-Cancer Patients Within 10 Years

R. Babela, V. Krčméry, A. Líšková, 2004, Infection Control & Hospital Epidemiology.

European Surveillance of Infections in Cancer Patients – ESIC

W. Hiddemann, X. Schiel, D. Buchheidt, 1999, Chemotherapy.

European Surveillance of Infections and Risk Factors in Cancer Patients

W. Hiddemann, J. Donnelly, X. Schiel, 1999, European Journal of Clinical Microbiology and Infectious Diseases.

Stenotrophomonas maltophilia bacteraemia in cancer patients: report on 31 cases.

P. Pichna, V. Krčméry, I. Krupova, 1996, The Journal of hospital infection.

Nephrotoxicity of aminoglycosides, polypeptides and cephalosporins in cancer patients.

R. Sobota, V. Krčméry, M. Gocar, 1991, Chemotherapy.

Endoparasitoses in hospitalised paediatric patients with pulmonary disease

J. Fabry, I. Papajová, V. Krčméry, 2014, Helminthologia.

Two cases of disseminated toxocariasis in compromised hosts successfully treated with mebendazole.

S. Špánik, I. Gould, V. Krčméry, 1992, Chemotherapy.

Epidemiology and geographical distribution of gastrointestinal parasitic infection in humans in Slovakia

V. Krčméry, P. Juriš, S. Jurišová, 2016 .

The Incidence of Pinworm (Enterobius Vermicularis) in Pre-school and School Aged Children in the Eastern Slovakia

V. Vargova, V. Krčméry, V. Krcmery, 2018, Helminthologia.

Nosocomial Postsurgical Meningitis in Children A 12-Year Survey Comparing Data From 1993-1998 With Data From 1999-2004

V. Balik, I. Sulla, I. Stankovič, 2006, Infection Control & Hospital Epidemiology.

Bacteremias caused by Escherichia coli in cancer patients - analysis of 65 episodes.

S. Špánik, J. Trupl, V. Krčméry, 2002, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Predictors of mortality in paediatric nosocomial meningitis: Results from 12 years national survey

V. Krčméry, E. Kalavsky, A. Ondrušová, 2006, Scandinavian journal of infectious diseases.

Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome.

S. Špánik, J. Trupl, V. Krčméry, 1998, The Journal of antimicrobial chemotherapy.

Quinolones in the Treatment of Community-Acquired Pneumonia in Neutropenic Patients

J. Mardiak, S. Špánik, V. Krčméry, 1993, Drugs.

Breakthrough nosocomial bacteraemia due to teicoplanin-resistant Staphylococcus haemolyticus in five patients with acute leukaemia.

S. Špánik, J. Trupl, V. Krčméry, 1997, The Journal of hospital infection.

Bacteremia due to methicillin-resistant staphylococci occurs more frequently in neutropenic patients who received antimicrobial prophylaxis and is associated with higher mortality in comparison to methicillin-sensitive bacteriemia.

J. Šufliarský, J. Mardiak, S. Špánik, 1998, International journal of antimicrobial agents.

Nosocomial Candida krusei fungemia in cancer patients: report of 10 cases and review.

S. Špánik, J. Trupl, V. Krčméry, 1999, Journal of chemotherapy.

BACTEREMIA DUE TO CIPROFLOXACIN-RESISTANT PSEUDOMONAS AERUGINOSA IN CANCERPATIENTS : RISK FACTORS FOR RESISTANCE AND OUTCOME OF 25 EPISODES. A CASE-C ONTROL STUDY

J. Trupl, V. Krčméry, A. Kunová, 1999 .

Hospital antibiotic management in Slovakia – results of the ABS maturity survey of the ABS International group

V. Krčméry, E. Kalavsky, 2008, Wiener klinische Wochenschrift.

Our experience with smartphone and spherical lens for the eye fundus examination during humanitarian project in Africa.

A. Furdová, V. Krčméry, Alena Furdova, 2017, International journal of ophthalmology.

Bacteremia due to Enterobacter spp. in cancer patients--analysis of 51 episodes.

S. Špánik, P. Pichna, J. Trupl, 1997, International journal of antimicrobial agents.

Resistance pattern of 2816 isolates isolated from 17631 blood cultures and etiology of bacteremia and fungemia in a single cancer institution.

S. Špánik, P. Pichna, J. Trupl, 1997, Acta oncologica.

Quality of Life, Risk Factors and Mortality in Children with HIV/AIDS on 2nd Line Treatment, Slow Progressors and Late Presenters in Cambodian Orphanage

S. Špánik, P. Horák, V. Krčméry, 2017 .

Religion and infectious diseases – review

S. Špánik, V. Krčméry, N. Bujdova, 2017 .

Increased consumption of fluoroquinolones is not associated with resistance in Escherichia coli and Staphylococcus aureus in the community.

V. Foltán, V. Krčméry, A. Líšková, 2001, The Journal of antimicrobial chemotherapy.

Routine surface disinfection in health care facilities: should we do it?

Andreas Voss, Markus Dettenkofer, Matteo Bassetti, 2002, American journal of infection control.

Confirmation of HIV-like sequences in respiratory tract bacteria of Cambodian and Kenyan HIV-positive pediatric patients

M. Mego, V. Stevurková, Z. Adamcikova, 2011, Medical science monitor : international medical journal of experimental and clinical research.

Candida famata Fungemia in a Cancer Patient: Case Report

V. Krčméry, A. Kunová, 2000, Journal of chemotherapy.

Imipenen-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome.

S. Špánik, Ľ. Drgoňa, V. Krčméry, 1996, International journal of clinical pharmacology research.

Oral antibiotic use in misdiagnosed infective endocarditis-no impact on mortality.

V. Hricák, M. Karvaj, V. Krčméry, 2007, International journal of antimicrobial agents.

First report of New Delhi metallo-β-lactamase-1-producing strains in Slovakia.

V. Krčméry, N. Kulková, M. Babálová, 2015, Microbial drug resistance.

Bacteraemia in cancer patients caused by colistin-resistant Gram-negative bacilli after previous exposure to ciprofloxacin and/or colistin.

V. Krčméry, A. Demitrovicova, P. Beno, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Bloodstream infections due to anaerobic bacteria in cancer patients: epidemiology, etiology, risk factors, clinical presentation and outcome of anaerobic bacteremia.

S. Špánik, P. Pichna, Ľ. Drgoňa, 1996, Neoplasma.

Use of fluconazole is not associated with a higher incidence of Candida krusei and other non-albicans Candida species.

J. Trupl, V. Krčméry, A. Kunová, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fungemia in children with neoplastic diseases.

S. Špánik, E. Kaiserova, V. Krčméry, 1998, The Pediatric infectious disease journal.

Infective endocarditis in children--report of 20 cases from a national survey and comparison with adult endocarditis.

J. Smrek, M. Hrebík, V. Krčméry, 2000, Acta paediatrica.

The Use of Quinolones as Therapy in Granulocytopenic Cancer Patients

V. Krčméry, 2012, Drugs.

Do vancomycin serum levels predict failures of vancomycin therapy or nephrotoxicity in cancer patients?

S. Špánik, V. Krčméry, A. Demitrovicova, 1997, Journal of chemotherapy.